Release Date: 16/01/23 19:54 Summary: Change in substantial holding from GMD Price Sensitive: No Download Document 124.28KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%